Skip to content
value.today

Accutar Biotechnology Inc.

🇺🇸 New York, New York, USABiotechnologyFounded 2015
Total raised
$76 M
3 rounds on record
Latest round
$28 M
Dec 2020
First round on record
Jul 2019
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Accutar Biotechnology Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$28 MNo. 3$10 to $50 million

Accutar Biotechnology Inc.: Raise no. 3, Dec 2020

Investors in this round

5 investors had bought by the notice of Jan 5, 2021: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $28 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jie Fan · Executive Officer, Director
  • Ke Liu · Executive Officer
  • Wei He · Executive Officer
  • Xiangyan Sun · Executive Officer
  • Yimin Qian · Executive Officer
  • Ling Zou · Director
  • Long Zhu · Director
  • Quan Zhou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jie Fan, Ceo. Source: SEC Form D, newest notice filed Jan 5, 2021. Read the notice at the SEC.

equitySEC
Aug 2020$20 MNo. 2$10 to $50 million

Accutar Biotechnology Inc.: Raise no. 2, Aug 2020

Investors in this round

1 investor had bought by the notice of Sep 2, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jie Fan · Executive Officer, Director
  • Ke Liu · Executive Officer
  • Wei He · Executive Officer
  • Xiangyan Sun · Executive Officer
  • Yimin Qian · Executive Officer
  • Ling Zou · Director
  • Long Zhu · Director
  • Quan Zhou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jie Fan, Ceo. Source: SEC Form D, newest notice filed Sep 2, 2020. Read the notice at the SEC.

equitySEC
Jul 2019$28 MNo. 1$10 to $50 million

Accutar Biotechnology Inc.: Raise no. 1, Jul 2019

Investors in this round

3 investors had bought by the notice of Aug 1, 2019: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $28 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jie Fan · Executive Officer, Director
  • Ke Liu · Executive Officer
  • Wei He · Executive Officer
  • Xiangyan Sun · Executive Officer
  • Yimin Qian · Executive Officer
  • Long Zhu · Director
  • Quan Zhou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jie Fan, Ceo. Source: SEC Form D, newest notice filed Aug 1, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Accutar Biotechnology Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2021).

    SEC Form D · Jan 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2021

That is all the official record says: Accutar Biotechnology Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Accutar Biotechnology Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 5 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Accutar Biotechnology Inc.
NameRoleNamed in
Jie FanExecutive officerJan 2021
Ke LiuExecutive officerJan 2021
Wei HeExecutive officerJan 2021
Xiangyan SunExecutive officerJan 2021
Yimin QianExecutive officerJan 2021
Jie FanDirectorJan 2021
Ling ZouDirectorJan 2021
Long ZhuDirectorJan 2021
Quan ZhouDirectorJan 2021